Introduction There are no established doctrines for treating Bells facial nerve paralysis (Bell's palsy), as there are still controversies in relation to the etiology of the disease. According to available sources 75% of all patients experience minor damage to the myelin sheath, thus usually recovering spontaneously and with no particular treatment. However, the rest of the patients may, without adequate treatment, experience a host of serious complications, starting from prolonged weakness of facial muscles, syncretism, hyperkinesias, contractions, even complete paralysis of facial muscles. All this may eventually lead to pronounced psychological problems. The initial therapy administered by maxillofacial surgeons is different from the one prescribed by neurologist, since maxillofacial surgeons recommend nerve blocks using 2% Xylocaine introduced in the stylomastoid area, accompanied by vitamin, anti-viral and non-corticosteroid anti-edema treatment.
Download full-text PDF |
Source |
---|
J Clin Med
December 2024
Department of Pediatrics, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Bell's palsy (BP) is a neurological disorder characterized by sudden unilateral peripheral facial paralysis. The etiology in children remains largely unknown, and standardized management strategies are lacking. The aim of this retrospective cohort study is to evaluate clinical features, laboratory markers, and therapeutic options associated with recovery to identify potential prognostic factors and validate therapeutic strategies, with a particular focus on the role of corticosteroids and vitamin supplementation.
View Article and Find Full Text PDFEur Arch Otorhinolaryngol
January 2025
Department of Otolaryngology-Head and Neck Surgery, Temerty Faculty of Medicine, University of Toronto, 6 Queen's Park Crescent West, Suite 120, Toronto, ON, M5S 3H2, Canada.
Purpose: The SARS-CoV-2 vaccination has reduced COVID-19 infection, though facial nerve palsy (FNP) has emerged as a notable side effect of the vaccine. We evaluated the current literature on the clinical presentation and outcomes of FNP related to COVID-19 vaccination.
Methods: A comprehensive search of seven databases was conducted for studies up to January 2023.
Laryngoscope
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, U.S.A.
Background: Incidence data on Facial Nerve Disorders (FND) and Bell's palsy are currently limited. Prior epidemiological studies have estimated the incidence rate of Bell's palsy to be between 11 and 53/100,000 individuals, although the most cited incidence data are from single regions or municipalities, many of which are outdated from several decades ago.
Methods: This was a retrospective cohort study of US adults from 2007 to 2022 using the Merative™ Marketscan® Research Databases.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
January 2025
To exploring the value of MR neuroimaging for quantitative assessment of the facial nerve and peripheral lymph nodes in patients with acute peripheral facial paralysis. Based on a prospective experimental design, 32 patients with idiopathic peripheral facial palsy were enrolled in the experiment. Based on MR neuroimaging technology, MR high-resolution thin-layer images of bilateral facial nerves were acquired.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!